Ingevity Corp (NGVT) valuation
Ingevity P/E ratio history
Ingevity trades at 49.2 times its earnings over the last twelve months and 13.2 times the earnings analysts expect over the next twelve. At its last 7 fiscal year ends its P/E ranged from 12.8 (year to Dec 2022) to 65.3 (year to Dec 2016), with a median of 21.1.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Dec 31, 2025 | $59.18 | -$4.61 | n/m | 12.1 |
| Dec 31, 2024 | $40.75 | -$11.85 | n/m | 10.9 |
| Dec 31, 2023 | $47.22 | -$0.15 | n/m | 13.0 |
| Dec 31, 2022 | $70.44 | $5.50 | 12.8 | 10.1 |
| Dec 31, 2021 | $71.70 | $2.95 | 24.3 | — |
| Dec 31, 2020 | $75.73 | $4.37 | 17.3 | — |
| Dec 31, 2019 | $87.38 | $4.34 | 20.1 | — |
| Dec 31, 2018 | $83.69 | $3.97 | 21.1 | — |
| Dec 31, 2017 | $70.47 | $2.97 | 23.7 | — |
| Dec 31, 2016 | $54.86 | $0.84 | 65.3 | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Ingevity valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| IngevityNGVT | $2.58B | 49.2 | 13.2 | 2.2 |
| Quaker HoughtonKWR | $2.60B | 27.1 | 16.5 | 1.3 |
| Hb FullerFUL | $2.67B | 13.9 | 9.8 | 0.8 |
| Ardagh Metal Packaging SaAMBP | $2.69B | 56.3 | 15.9 | 0.4 |
| InnospecIOSP | $2.46B | 20.4 | 18.0 | 1.3 |
| Usa Rare EarthUSAR | $2.15B | — | — | 163.1 |
| Constellium SeCSTM | $3.13B | 5.7 | 7.6 | 0.3 |
| HawkinsHWKN | $3.18B | 37.0 | 34.6 | 2.8 |
| United States Lime And Minerals InUSLM | $3.20B | 23.9 | 20.8 | 8.5 |
| Peer median | 23.9 | 16.5 | 1.3 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: NGVT financials · NGVT returns
No forecast, no recommendation. This page describes Ingevity Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.